After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine
According to the Oxford University release, no volunteer complained of any medical issue during the trial of the vaccine.
Full Article
After Pfizer and Moderna, Oxford-AstraZeneca claims 90% efficacy of COVID-19 vaccine
DNA
0 shares
1 views
You might like
Related news coverage
Crude oil prices hit 8-month highs on improving risk sentiment
Invezz
Crude oil prices are trading at the highest levels since March on positive news related to Covid-19 vaccine and diminishing..
-
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
-
Moderna asking US, European regulators to greenlight COVID-19 vax
Mid-Day
-
Coronavirus: UK expected to approve Pfizer/BioNTech vaccine this week, acquires 2mln extra doses of Moderna jab
Proactive Investors
-
UK stocks up on vaccines, hopes to start virus shots in days
SeattlePI.com
Advertisement
More coverage
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
AstraZeneca PLC (LON:AZN) said it is mulling undertaking a new trial for the coronavirus (COVID-19) vaccine developed with Oxford..
-
UK asks regulator to assess AZ-Oxford vaccine amid questions
SeattlePI.com
-
Mumbai travel firm offers US holiday package for Rs 1.75 lakh with promise of COVID-19 vaccine
Mid-Day
-
AstraZeneca-Oxford vaccine: 5 reasons that makes it better than Pfizer-BioNTech SE and Moderna shots
DNA
-
Sputnik’s ‘efficacy at 95%’, to be cheaper than US vaccines
IndiaTimes